These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8961075)

  • 1. Role of endothelin in a rabbit model of acute myocardial infarction: effects of receptor antagonists.
    Vitola JV; Forman MB; Holsinger JP; Kawana M; Atkinson JB; Quertermous T; Jackson EK; Murray JJ
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):774-83. PubMed ID: 8961075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion.
    McMurdo L; Thiemermann C; Vane JR
    Br J Pharmacol; 1994 May; 112(1):75-80. PubMed ID: 8032665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation into the potential anti-inflammatory effects of endothelin antagonists in a murine model of experimental monosodium urate peritonitis.
    Getting SJ; Di Filippo C; Lam CW; Rossi F; D'Amico M
    J Pharmacol Exp Ther; 2004 Jul; 310(1):90-7. PubMed ID: 14996949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor.
    McMurdo L; Lidbury PS; Thiemermann C; Vane JR
    Br J Pharmacol; 1993 Jun; 109(2):530-4. PubMed ID: 8358553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion.
    Gupta SK; Saxena A; Singh U; Arya DS
    Mol Cell Biochem; 2005 Jul; 275(1-2):67-74. PubMed ID: 16335785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
    Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
    Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats.
    Watanabe T; Awane Y; Ikeda S; Fujiwara S; Kubo K; Kikuchi T; Kusumoto K; Wakimasu M; Fujino M
    Br J Pharmacol; 1995 Mar; 114(5):949-54. PubMed ID: 7780649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fukai D; Kinoshita M
    Cardiovasc Res; 1998 Sep; 39(3):617-24. PubMed ID: 9861304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-receptor antagonist FR 139317 reduces infarct size in a rabbit model when given before, but not after, coronary artery occlusion.
    Burke SE; Nelson RA
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):87-92. PubMed ID: 9007676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarafotoxin 6c (S6c) reduces infarct size and preserves mRNA for the ETB receptor in the ischemic/reperfused myocardium of anesthetized rats.
    Crockett TR; Gray GA; Kane KA; Wainwright CL
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):148-54. PubMed ID: 15243294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-A and -B antagonists protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model.
    Szabó G; Fazekas L; Bährle S; MacDonald D; Stumpf N; Vahl CF; Hagl S
    Cardiovasc Res; 1998 Sep; 39(3):683-90. PubMed ID: 9861312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.
    Richard V; Kaeffer N; Hogie M; Tron C; Blanc T; Thuillez C
    Br J Pharmacol; 1994 Nov; 113(3):869-76. PubMed ID: 7858879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antagonists for endothelin ET(A) and ET(B) receptors on coronary endothelial and myocardial function after ischemia-reperfusion in anesthetized goats.
    Climent B; Fernández N; García-Villalón AL; Monge L; Sánchez A; Diéguez G
    Vascul Pharmacol; 2006 May; 44(5):384-90. PubMed ID: 16580265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
    Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
    Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endothelin-1 receptors in healthy anaesthetized rabbits.
    Schmitz-Spanke S; Schipke J
    Clin Exp Pharmacol Physiol; 2001 Aug; 28(8):647-50. PubMed ID: 11473531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 release during the early phase of reperfusion is a mediator of myocardial reperfusion injury.
    Tamareille S; Terwelp M; Amirian J; Felli P; Zhang XQ; Barry WH; Smalling RW
    Cardiology; 2013; 125(4):242-9. PubMed ID: 23816794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelin-A receptors in ischemic contracture and reperfusion injury.
    Brunner F; Opie LH
    Circulation; 1998 Feb; 97(4):391-8. PubMed ID: 9468213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bosentan affects 15-F2t-isoprostane adverse effects on postischemic rat hearts.
    Liu HM; Liu KX; Cheng MH; Liu Y; Lei S; Irwin MG; Xia Z
    J Surg Res; 2011 Jun; 168(1):18-26. PubMed ID: 20006348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin receptor antagonist BQ-123 ameliorates myocardial ischemic-reperfusion injury in rats: a hemodynamic, biochemical, histopathological and electron microscopic evidence.
    Goyal SN; Bharti S; Arora S; Golechha M; Arya DS
    Biomed Pharmacother; 2010 Nov; 64(9):639-46. PubMed ID: 20888175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.